LYRIX
Price
$26.46
Change
-$0.13 (-0.49%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

LYRIX vs VMVAX

Header iconLYRIX vs VMVAX Comparison
Open Charts LYRIX vs VMVAXBanner chart's image
Lyrical US Value Equity Institutional
Price$26.46
Change-$0.13 (-0.49%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
LYRIX vs VMVAX Comparison Chart
Loading...
VS
LYRIX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYRIX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. LYRIX (876M). VMVAX pays higher dividends than LYRIX: VMVAX (2.14) vs LYRIX (0.39). LYRIX was incepted earlier than VMVAX: LYRIX (12 years) vs VMVAX (13 years). LYRIX (23.00) and VMVAX (22.00) have comparable annual turnover. VMVAX has a lower initial minimum investment than LYRIX: VMVAX (3000) vs LYRIX (100000). LYRIX annual gain was more profitable for investors over the last year : 32.67 vs. VMVAX (25.35). LYRIX return over 5 years is better than : 74.40 vs. VMVAX (48.82).
LYRIXVMVAXLYRIX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years13 years-
Gain YTD15.49514.946104%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets876M30.5B3%
Annual Yield % from dividends0.392.1418%
Returns for 1 year32.6725.35129%
Returns for 3 years27.2520.71132%
Returns for 5 years74.4048.82152%
Returns for 10 years74.84100.8874%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio